Intraoperative Ketorolac and Bleeding after Laparoscopic Roux-En-Y Gastric By-Pass Surgery

References

• Buchwald H., Avidor Y., Braunwald E. et al. Bariatric surgery: a systematic review and meta-analysis. JAMA, 2004, 292: 17241737.
   Google Scholar
• Podnos Y. D., Jimenez J. C., Wilson S. E., Stevens C. M., Nguyen N. T. Complications after laparoscopic gastric bypass: a review of 3464 cases. Arch Surg, 2003, 138: 957–961.
   Google Scholar
• Mehran A., Szomstein S., Zundel N., Rosenthal R. Management of acute bleeding after laparoscopic Roux-en-Y gastric bypass. Obes Surg, 2003, 13: 842–847.
   Google Scholar
• Reuben S. S. Update on the role of nonsteroidal anti-inflammatory drugs and coxibs in the management of acute pain. Curr Opin Anaesthesiol, 2007, 20: 440–450.
   Google Scholar
• Bakhos C., Alkhoury F., Kyriakides T., Reinhold R., Nadzam G. Early postoperative hemorrhage after open and laparoscopic roux-en-y gastric bypass. Obes Surg, 2009, 19: 153–157.
   Google Scholar
• Strom B. L., Berlin J. A., Kinman J. L. et al. Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study. JAMA, 1996, 275: 376–382.
   Google Scholar
• Sinha V. R., Kumar R. V., Singh G. Ketorolac tromethamine formulations: an overview. Expert Opin Drug Deliv, 2009, 6: 961975.
   Google Scholar
• Gillis J. C., Brogden R. N. Ketorolac. A reappraisal of its pharma-codynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs, 1997, 53: 139–188.
   Google Scholar
• Greer I. A. Effects of ketorolac tromethamine on hemostasis. Pharmacotherapy, 1990, 10: 71S-76S.
   Google Scholar
• Garcia Rodriguez L. A., Cattaruzzi C., Troncon M. G., Agostinis L. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Arch Intern Med, 1998, 158: 33–39.
   Google Scholar
• Lanas A., Garcia-Rodriguez L. A., Arroyo M. T. et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut, 2006, 55: 1731–1738.
   Google Scholar
• Laporte J. R., Ibanez L., Vidal X., Vendrell L., Leone R. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Saf, 2004, 27: 411–420.
   Google Scholar
• Llorente Melero M. J., Tenias Burillo J. M., Zaragoza M. A. Comparative incidence of upper gastrointestinal bleeding associated with individual non-steroidal anti-inflammatory drugs. Rev Esp Enferm Dig, 2002, 94: 7–18.
   Google Scholar
• Masso Gonzalez E. L., Patrignani P., Tacconelli S., Garcia Rodriguez L. A. Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum, 2010, 62: 1592–1601.
   Google Scholar
• Chang C. H., Shau W. Y., Kuo C. W., Chen S. T., Lai M. S. increased risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study. Stroke, 2010, 41: 1884–1890.
   Google Scholar
• Forrest J. B., Camu F., Greer I. A. et al. Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery. Br J Anaesth, 2002, 88: 227–233.
   Google Scholar
• AgrawalA., Gerson C. R., Seligman I., DsidaR. M. Postoperative hemorrhage after tonsillectomy: use of ketorolac tromethamine. Otolaryngol Head Neck Surg, 1999, 120: 335–339.
   Google Scholar
• Bailey R., Sinha C., Burgess L. P. Ketorolac tromethamine and hemorrhage in tonsillectomy: a prospective, randomized, doubleblind study. Laryngoscope, 1997, 107: 166–169.
   Google Scholar
• Splinter w. M., Rhine E. J., Roberts D. W., Reid C. W., MacNeill H. B. Preoperative ketorolac increases bleeding after tonsillectomy in children. Can J Anaesth, 1996, 43: 560–563.
   Google Scholar
• Vuilleumier H., Halkic N. Ruptured subcapsular hematoma after laparoscopic cholecystectomy attributed to ketorolac-induced coagulopathy. Surg Endosc, 2003, 17: 659.
   Google Scholar
• Erstad B. L., Rappaport W. D. Subcapsular hematoma after laparoscopic cholecystectomy, associated with ketorolac administration. Pharmacotherapy, 1994, 14: 613–615.
   Google Scholar
• Fragen R. J., Stulberg S. D., Wixson R., Glisson S., Librojo E. Effect of ketorolac tromethamine on bleeding and on requirements for analgesia after total knee arthroplasty. J Bone Joint Surg Am, 1995, 77: 998–1002.
   Google Scholar
• Hamad G. G., Choban P S. Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study. Ohes Surg, 2005, 15: 13681374.
   Google Scholar
• Scholten D. J., Hoedema R. M., Scholten S. E. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg, 2002, 12: 19–24.
   Google Scholar
• Bauer K. A., Gerson W., Wright C. et al. Platelet function following administration of a novel formulation of intravenous diclofenac sodium versus active comparators: a randomized, single dose, crossover study in healthy male volunteers. J Clin Anesth, 2010, 22: 510–518.
   Google Scholar
• Singer A. J., Mynster C. J., McMahon B. J. The effect of IM ketorolac tromethamine on bleeding time: a prospective, interven-tional, controlled study. Am J Emerg Med, 2003, 21: 441–443.
   Google Scholar
• Greer I. A., Gibson J. L., Young A., Johnstone J., Walker I. D. Effect of ketorolac and low-molecular-weight heparin individually and in combination on haemostasis. Blood Coagul Fibrinolysis, 1999, 10: 367–373.
   Google Scholar
• Delaporte-Cerceau S., Samama C. M., Riou B. et al. Ketorolac and enoxaparin affect arterial thrombosis and bleeding in the rabbit. Anesthesiology, 1998, 88: 1310–1317.
   Google Scholar
• Green D., Klement P., Liao P., Weitz J. Interaction of low molecular weight heparin with ketorolac. J Lab Clin Med, 1996, 127: 583–587.
   Google Scholar
• Weale A. E., Warwick D. J., Durant N., Prothero D. Is there a clinical interaction between low molecular weight heparin and non-steroidal analgesics after total hip replacement ? Ann R Coll Surg Engl, 1995, 77: 35–37.
   Google Scholar